Jim Tananbaum: The Visionary at Foresite Capital Investments

Mindstrong Health specializes in the use of smartphones in providing diagnosis and help to patients with neuropsychiatric disorders. Recently, it acquired $14 million Series A funding from various investors. These investors include ARCH Venture partners, Foresite Capital, Optum Ventures, and One Mind Brain Health Impact Fund. Mindstrong’s AI powered digital platform facilitates the recording of patients’ scrolling and typing habits to evaluate brain functions. As a result, its clinical team can obtain information related to cognition and mood biomarkers to determine a patient’s memory, attention threshold, processing capacity, and command execution.

 

Collected data helps the startup gain insights into how humans think, behave, and interact like never before. This, in turn, will assist the medical community to improve service delivery to patients with cognitive disorders. Acquired funding is expected to help the company develop the technology used in tracking of mental health disorders in clinical settings. As such, this technology will enhance psychiatric disorders assessment methods and mental illness interventions.

 

Who is Jim Tananbaum?

 

Jim Tananbaum is the co-founder and CEO of Foresite Capital Investment and is listed in Forbes Midas List of 100 influential investors. With over 25 years’ experience in healthcare investing, Tananbaum is in charge of Foresite Capital’s entrepreneurial and healthcare investments. Before co-founding Foresite Capital, Jim co-founded four companies inclusive of two biopharm businesses and two health investment practices. At Harvard, he founded GelTex Pharmaceuticals with over $ 1 billion in revenue. Another company founded by Tananbaum is Theravance Inc. valued at $2.75 billion. As an investor, Tananbaum was a partner at Prospect Venture Partners as well as at Sierra Ventures. Additionally, he initiated and led various investment practices inclusive of Amerigroup, Amira Pharmaceuticals, Healtheon, and Jazz Pharmaceuticals.

 

According to Medium, Jim graduated from Harvard Business School and Medical School with an MBS and Doctor of Medicine (MD) respectively. He holds a BS and BSEE in Math and Computer Science from Yale University and a Master of Science in Information Theory from MIT. Over the years, he served on various committees and advisory boards to Harvard’s-MIT HST program and is president of Yale’s Advisory Council. Jim Tananbaum is passionate about working with entrepreneurs, academicians, and medical professionals to create insights in deep learning and science. His vision entails combining his professional experiences in developing novel and unique investment platforms.

 

Read More: https://ideamensch.com/jim-tananbaum/

Leave a Reply